First of new generation of cancer drugs granted European approval

18 Dec 2014

A new drug for ovarian cancer, developed by researchers at the University of Cambridge and AstraZeneca, has today become the first of new class of drugs, known as PARP-inhibitors, to be granted approval anywhere in the world. The drug, Lynparza, has been granted Marketing Authorisation from the European Commission.

Read More

Lighter planes are the future

16 Dec 2014

A global fleet of composite planes could reduce carbon emissions by up to 15 per cent, but the lighter planes alone will not enable the aviation industry to meet its emissions targets, according to new research.

Read More

New understanding of how magma moves underground

15 Dec 2014

An international team of geoscientists have demonstrated how magma-filled cracks form and spread underneath volcanic systems, such as the one extending from Iceland’s Bárðarbunga volcano to an eruptive site which has now been active for more than 100 days.

Read More

Supplement could reduce heart disease risk in people of low birth weight

10 Dec 2014

A simple supplement could be a safe and cost-effective way of reducing heart disease in individuals born with a low birth weight, suggests research from the University of Cambridge. The study, carried out in rats, also raises the possibility of developing a blood test to indicate how much damage there is in the aortas of these individuals.

Read More

Pages